# Case Report: Vogt–Koyanagi–Harada syndrome complicated by secondary glaucoma: diagnostic insights and mechanistic correlations in uveitic ocular hypertension

**Authors:** Fenglong Li, Dongshen Wu, Xiaowei Zhu

PMC · DOI: 10.3389/fmed.2026.1755451 · Frontiers in Medicine · 2026-02-10

## TL;DR

A rare case of Vogt–Koyanagi–Harada syndrome presented as acute angle-closure glaucoma, emphasizing the need for accurate diagnosis and anti-inflammatory treatment.

## Contribution

The case emphasizes the diagnostic value of ciliary body imaging and the mechanistic link between inflammation and secondary angle closure.

## Key findings

- VKH syndrome can present with acute angle-closure glaucoma as an initial manifestation.
- Ciliary body detachment and serous retinal detachments were identified through imaging.
- Early anti-inflammatory treatment improved visual acuity and resolved subretinal fluid.

## Abstract

This case highlights an uncommon presentation of Vogt–Koyanagi–Harada (VKH) syndrome, in which acute angle-closure glaucoma (AACG) served as the initial ocular manifestation. This atypical onset may lead to misdiagnosis as primary angle-closure glaucoma. This report adds to the existing literature by emphasizing the diagnostic value of ciliary body imaging and the mechanistic link between inflammatory ciliary body detachment and secondary angle closure.

A 27-year-old woman presented with acute ocular pain, vision loss, and markedly elevated intraocular pressure (IOP). Important clinical findings included conjunctival congestion, corneal edema, medium-depth anterior chambers, and the absence of keratic precipitates or aqueous flare. Ultrasound biomicroscopy revealed a ciliary body detachment, whereas optical coherence tomography revealed multiple serous retinal detachments. The patient was initially misdiagnosed with glaucoma before a revised diagnosis of VKH syndrome-associated secondary AACG was made.

The patient was treated with intravenous methylprednisolone pulse therapy combined with topical corticosteroids, mydriatic agents, and IOP-lowering agents. Visual acuity and IOP gradually improved, and subretinal fluid completely resolved during follow-up.

VKH syndrome rarely presents with AACG as the initial manifestation. Awareness of this presentation and careful imaging evaluation are essential to avoid misdiagnosis. Early and aggressive anti-inflammatory therapy remains key to reversing both angle closure and retinal pathology. This case highlights the importance of considering autoimmune uveitis in patients with atypical angle-closure glaucoma.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** Vogt–Koyanagi–Harada syndrome (MONDO:0018092), acute angle-closure glaucoma (MONDO:0001817), uveitis (MONDO:0020283)

## Full-text entities

- **Diseases:** body detachment (MESH:D012163), angle (MESH:D009464), AACG (MESH:D015812), anterior synechiae (MESH:D006175), granulomatous panuveitis (MESH:D015864), laxity (MESH:D007593), corneal edema (MESH:D015715), corneal opacity (MESH:D003318), Behcet's disease (MESH:D001528), uveitic ocular hypertension (MESH:D009798), autoimmune disease (MESH:D001327), autoimmune uveitis (MESH:D014605), glaucoma (MESH:D005901), VKH Disease (MESH:D014607), sympathetic ophthalmia (MESH:D009879), conjunctival congestion (MESH:D003229), central serous chorioretinopathy (MESH:D056833), pupillary dilation (MESH:D002311), tinnitus (MESH:D014012), malignant glaucoma (MESH:D009369), ocular pain (MESH:D058447), birdshot retinochoroidopathy (MESH:D000080365), vitiligo (MESH:D014820), edema (MESH:D004487), headache (MESH:D006261), anterior chamber inflammation (MESH:D007249), trauma (MESH:D014947), subretinal (MESH:D006949), C,D (MESH:D019701), decreased vision (MESH:D014786), pupil dilation (MESH:D011681)
- **Chemicals:** steroid (MESH:D013256), methylprednisolone (MESH:D008775), fluorescein (MESH:D019793), IOP-lowering agents (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930358/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930358/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930358/full.md

---
Source: https://tomesphere.com/paper/PMC12930358